The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.08BCNY
1.06B · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
1.08BCNY
162.12M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-12.99%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Beta
0.4120x
vs all stocks
Updated Oct 21, 2026
52-Week Change
19.01%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
7.08BCNY
1.06B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
9.10BCNY
1.36B · vs all stocks (USD)
Updated Oct 21, 2026
Forward P/E
33.73x
vs Aerospace & Defense peers
Updated Oct 21, 2026
Price to Sales (TTM)
6.34x
vs Aerospace & Defense peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 6.54×.Updated Oct 21, 2026
Price to Book (MRQ)
3.49x
vs Aerospace & Defense peers
Updated Oct 21, 2026
Enterprise to Revenue
8.41x
vs Aerospace & Defense peers
Updated Oct 21, 2026
Enterprise to EBITDA
83.31x
vs Aerospace & Defense peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 36.56×.Updated Oct 21, 2026
Gross Margin
22.83%
vs Aerospace & Defense peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.19%.Updated Oct 21, 2026
Profit Margin
-12.99%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Operating Margin
5.37%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Return on Assets (TTM)
-1.31%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Return on Equity (TTM)
-7.16%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Revenue (TTM)
1.08BCNY
162.12M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
3.71CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
30.30%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Gross Profit (TTM)
110.17MCNY
16.51M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
248.77MCNY
37.29M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-140.46MCNY
-21.05M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-28.60%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
50.97MCNY
7.64M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-45.03MCNY
-6.75M · vs all stocks (USD)
Updated Oct 21, 2026
Payout Ratio
100.00%
vs Aerospace & Defense peers
Updated Oct 21, 2026
Minority Interest (Equity)
246.95MCNYFY2025 · Dec 31, 2025
Revenue
1.01BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
836.69MCNYFY2025 · Dec 31, 2025
Gross Profit
176.54MCNYFY2025 · Dec 31, 2025
Operating Income
-3.29MCNY
-493.30K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-111.32MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-15.83MCNYFY2025 · Dec 31, 2025
Net Income
-95.48MCNYFY2025 · Dec 31, 2025
EBIT
-22.46MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
248.77MCNYFY2025 · Dec 31, 2025
Research & Development
71.07MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
43.78MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
18.56MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
783.44KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
88.86MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.3500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.3500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
292.07MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
292.07MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-95.48MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-6.74MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-121.08MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-319.97MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
212.08MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-95.48MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
110.64MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
41.67MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-177.90MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-198.90MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-16.20MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.15MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-40.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-253.94MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
784.53MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-769.40MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-62.73MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-70.84MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-118.45MCNYFY2025 · Dec 31, 2025
Shares Outstanding
327.72MSharesUpdated Oct 21, 2026
Float Shares
232.35MSharesUpdated Oct 21, 2026
% Held by Insiders
25.98%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
9.66%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
200.95MCNY
30.12M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
0.6200CNYUpdated Oct 21, 2026
Total Debt (MRQ)
2.27BCNY
340.76M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
1.04x
vs Aerospace & Defense peers
Updated Oct 21, 2026
Current Ratio (MRQ)
1.40x
vs Aerospace & Defense peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
6.00CNYUpdated Oct 21, 2026
Total Assets
4.90BCNY
734.61M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.95BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.40BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.95BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.79BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.62BCNYFY2025 · Dec 31, 2025
Cash
212.08MCNYFY2025 · Dec 31, 2025
Cash Equivalents
209.19KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
212.28MCNYFY2025 · Dec 31, 2025
Accounts Receivable
671.25MCNYFY2025 · Dec 31, 2025
Inventory
819.32MCNYFY2025 · Dec 31, 2025
Accounts Payable
500.05MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.01BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
43.65MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.58BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
297.18MCNYFY2025 · Dec 31, 2025
Retained Earnings
208.35MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.50BCNY
224.81M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
75.50MCNYFY2025 · Dec 31, 2025
52-Week Low
16.45CNYUpdated Oct 21, 2026
52-Week High
52.00CNYUpdated Oct 21, 2026
52-Week Change
19.01%
vs all stocks
Updated Oct 21, 2026
Beta
0.4120x
vs all stocks
Updated Oct 21, 2026
50-Day MA
22.63CNYUpdated Oct 21, 2026
200-Day MA
33.12CNYUpdated Oct 21, 2026
Avg 10-Day Volume
18.78MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
12.96MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-0.4800CNYUpdated Oct 21, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has compounded over six years while gross profit and net income fell over four.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.